Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Diffuse Large B-Cell Lymphoma (DLBCL) of the paranasal sinuses (PNS) is an uncommon manifestation of non-Hodgkin lymphoma (NHL), accounting for 0.2-2% of all DLBCL cases. Despite DLBCL being the most frequent subtype of NHL, its occurrence in the PNS is rare, often leading to diagnostic delays due to nonspecific symptoms. The disease primarily affects older adults with a slight male predominance and presents with nasal obstruction, proptosis, and vision loss, among other symptoms. Diagnosis is challenging due to its similarity to more common sinonasal conditions like sinusitis, and timely identification is crucial given DLBCL's aggressive nature. This report presents three cases of DLBCL in the PNS, each characterized by progressive symptoms such as headache, nasal discharge, proptosis, and vision loss. All three patients were treated in a tertiary care center in North India. In each case, diagnostic imaging, histopathological examination, and immunohistochemical staining were utilized to confirm DLBCL. The patients underwent endoscopic biopsy and received chemotherapy, with varying degrees of response. Treatment challenges, particularly in patients with advanced disease, were highlighted, including the potentialfor irreversible vision loss and the high risk of relapse. A literature review further supports that DLBCL of the PNS is a rare but significant diagnosis requiring prompt recognition and treatment. Review of similar cases emphasizes the importance of distinguishing this condition from other sinonasal tumorsand infections to ensure proper management and improved patient outcomes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12103454PMC
http://dx.doi.org/10.1007/s12070-025-05505-5DOI Listing

Publication Analysis

Top Keywords

vision loss
12
diffuse large
8
paranasal sinuses
8
pns rare
8
proptosis vision
8
dlbcl pns
8
dlbcl
6
intriguing cases
4
cases diffuse
4
large cell
4

Similar Publications

Retinitis pigmentosa (RP) affects around 1 in 4000 individuals and represents approximately 25% of cases of vision loss in adults, through death of retinal rod and cone photoreceptor cells. It remains a largely untreatable disease, and research is needed to identify potential targets for therapy. Mutations in 94 different genes have been identified as causing RP, including AGBL5 which encodes the main deglutamylase that regulates and maintains functional levels of cilia tubulin glutamylation, which is essential to initiate ciliogenesis, maintain cilia stability and motility.

View Article and Find Full Text PDF

Background: Blepharitis, meibomian gland dysfunction (MGD), and chalazia are common disorders impacting quality of life. This population-based, pharmacovigilance study aims to identify systemic drugs disproportionately linked to these disorders.

Methods: Data from the Food and Drug Administration Adverse Event Reporting System (FAERS) were analysed (Q4 2003 to Q2 2024).

View Article and Find Full Text PDF

BackgroundGlaucoma is recognized as the second-leading cause of complete blindness in developed countries and a significant contributor to irreversible vision loss worldwide. Understanding the potential genetic links between neurodegenerative diseases, such as Parkinson's disease, and glaucoma is crucial for developing preventive strategies.MethodsThis study utilized data from Genome-Wide Association Studies databases, focusing on European populations without gender restrictions.

View Article and Find Full Text PDF

In the visual cortices, receptive fields (RFs) are arranged in a gradient from small sizes in the center of the visual field to the largest sizes at the periphery. Using functional magnetic resonance imaging (fMRI) mapping of population RFs, we investigated RF adaptation in V1, V2, and V3 in patients after long-term photoreceptor degeneration affecting the central (Stargardt disease [STGD]) and peripheral (Retinitis Pigmentosa [RP]) regions of the retina. In controls, we temporarily limited the visual field to the central 10° to model peripheral loss.

View Article and Find Full Text PDF

Sorting nexin 3 promotes ischemic retinopathy through RIP1- and RIP3-mediated myeloid cell necroptosis and mitochondrial fission.

Proc Natl Acad Sci U S A

September 2025

State Key Laboratory of Bioactive Molecules and Druggability Assessment, Guangdong Province Key Laboratory of Pharmacodynamic Constituents of Traditional Chinese Medicine and New Drugs Research, International Cooperative Laboratory of Traditional Chinese Medicine Modernization and Innovative Drug De

Proliferative retinopathy is a leading cause of irreversible blindness in humans; however, the molecular mechanisms behind the immune cell-mediated retinal angiogenesis remain poorly elucidated. Here, using single-cell RNA sequencing in an oxygen-induced retinopathy (OIR) model, we identified an enrichment of sorting nexin (SNX)-related pathways, with SNX3, a member of the SNX family that is involved in endosomal sorting and trafficking, being significantly upregulated in the myeloid cell subpopulations of OIR retinas. Immunostaining showed that SNX3 expression is markedly increased in the retinal microglia/macrophages of mice with OIR, which is mainly located within and around the neovascular tufts.

View Article and Find Full Text PDF